Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuro...
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial
About this item
Full title
Author / Creator
Ladenstein, Ruth, Prof , Pötschger, Ulrike, MSc , Valteau-Couanet, Dominique, MD , Luksch, Roberto, MD , Castel, Victoria, MD , Yaniv, Isaac, Prof , Laureys, Genevieve, MD , Brock, Penelope, MD , Michon, Jean Marie, MD , Owens, Cormac, MD , Trahair, Toby, MD , Chan, Godfrey Chi Fung, MD , Ruud, Ellen, MD , Schroeder, Henrik, Prof , Beck Popovic, Maja, MD , Schreier, Guenter, PhD , Loibner, Hans, PhD , Ambros, Peter, PhD , Holmes, Keith, MD , Castellani, Maria Rita, MD , Gaze, Mark N, MD , Garaventa, Alberto, MD , Pearson, Andrew D J, Prof and Lode, Holger N, Prof
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
SummaryBackgroundImmunotherapy with the chimeric anti-GD2 monoclonal antibody dinutuximab, combined with alternating granulocyte-macrophage colony-stimulating factor and intravenous interleukin-2 (IL-2), improves survival in patients with high-risk neuroblastoma. We aimed to assess event-free survival after treatment with ch14.18/CHO (dinutuximab b...
Alternative Titles
Full title
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial
Authors, Artists and Contributors
Author / Creator
Pötschger, Ulrike, MSc
Valteau-Couanet, Dominique, MD
Luksch, Roberto, MD
Castel, Victoria, MD
Yaniv, Isaac, Prof
Laureys, Genevieve, MD
Brock, Penelope, MD
Michon, Jean Marie, MD
Owens, Cormac, MD
Trahair, Toby, MD
Chan, Godfrey Chi Fung, MD
Ruud, Ellen, MD
Schroeder, Henrik, Prof
Beck Popovic, Maja, MD
Schreier, Guenter, PhD
Loibner, Hans, PhD
Ambros, Peter, PhD
Holmes, Keith, MD
Castellani, Maria Rita, MD
Gaze, Mark N, MD
Garaventa, Alberto, MD
Pearson, Andrew D J, Prof
Lode, Holger N, Prof
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2157825842
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2157825842
Other Identifiers
ISSN
1470-2045
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(18)30578-3
